MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer.
Authors: Adam, Julien1,2,3, Sourisseau, Tony2,3, Olaussen, Ken A.1,2,3 ken.olaussen@gustaveroussy.fr, Robin, Angélique2,3, Zhu, Chang Q.4, Templier, Alexandre5, Civet, Alexandre5, Girard, Philippe6, Lazar, Vladimir2, Validire, Pierre6,7, Tsao, Ming S.4, Soria, Jean-Charles1,2,3, Besse, Benjamin1,2,3
Source: Cancer Biomarkers. 2016, Vol. 17 Issue 3, p323-333. 11p.
Database: Academic Search Ultimate
Description
ISSN:15740153
DOI:10.3233/CBM-160644